Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Incannex Healthcare Inc. publishes a filing, an earnings call transcript or a press release.
Get IXHL alertsJoseph Swan is recorded as CFO at Incannex Healthcare Inc. (IXHL). The newest filing on record that lists Joseph Swan as CFO at Incannex Healthcare Inc. (IXHL) is dated October 28, 2026. Incannex Healthcare Inc. reported in an 8-K filed March 5, 2024 that Joseph Swan was appointed Chief Financial Officer and Secretary, effective February 29, 2024. The proxy statement of Incannex Healthcare Inc. reports total compensation of $466,456 for Joseph Swan in fiscal 2026, including a base salary of $198,256. Disclosed compensation is on record for 3 fiscal years. Incannex Healthcare Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Incannex Healthcare Inc. includes Joel Latham (CEO and Board Member), Lekhram Changoer (CTO), Dr. George Anastassov (Board Member) and 2 others.
“The Company's Board of Directors has appointed Joseph Swan, the current Treasurer and Controller of the Company, as its Chief Financial Officer and Secretary effective as of February 29, 2024.”
Start not stated–present
Last confirmed October 28, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2026 | Incannex Healthcare Inc. (IXHL) | Chief Financial Officer | $198,256 | $466,456 |
| 2025 | Incannex Healthcare Inc. (IXHL) | Chief Financial Officer | $150,650 | $210,714 |
| 2024 | Incannex Healthcare Inc. (IXHL) | Chief Financial Officer | $107,940 | $264,007 |